Glucosamine increases vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aorta

BMB Reports

Volumn 44, Issue 6, 2011, Pages 415-420

  Kim, Do Hyung ^a   Seok, Young Mi ^a   Kim, In Kyeom ^a   Lee, In Kyu ^a,b   Jeong, Seong Yun ^c   Jeoung, Nam Ho ^a,c  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

Blood vessel constriction; Diabetes; Hypertension; O Glcnacylation; O linked N acetylglucosamine transferase; Rhoa

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; GLUCOSAMINE; PHENYLEPHRINE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASOCONSTRICTOR AGENT;

ANIMAL; AORTA; ARTICLE; CHEMISTRY; DRUG EFFECT; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AORTA; GLUCOSAMINE; MALE; PHENYLEPHRINE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

RATTUS;

EID: 79960084570     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.6.415     Document Type: Article

References (31)

1. Vosseller, K., Wells, L. and Hart, G. W. (2001) Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics. Biochimie. 3, 575-581.
2. Wells, L., Vosseller, K. and Hart, G. W. (2001) Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291, 2376-2378.
3. Hawkins, M., Angelov, I., Liu, R., Barzilai, N. and Rossetti, L. (1997) The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J. Biol. Chem. 272, 4889-4895.
4. Einstein, F. H., Fishman, S., Bauman, J., Thompson, R. F., Huffman, D. M., Atzmon, G., Barzilai, N. and Muzumdar, R. H. (2008) Enhanced activation of a "nutrient-sensing" pathway with age contributes to insulin resistance. FASEB J. 22, 3450-3457.
5. Hanover, J. A., Krause, M. W. and Love, D. C. (2010) The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim. Biophys. Acta. 1800, 80-95.
6. Buse, M. G. (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290, E1-E8.
7. Lorenzi, M. (1992) Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab. Rev. 8, 85-103.
8. Arias, E. B. and Cartee, G. D. (2005) Relationship between protein O-linked glycosylation and insulin- stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxyd-glucopyranosylidene) amino-N-phenylcarbamate. Acta. Physiol. Scand. 183, 281-289.
9. King, G. L., Kunisaki, M., Nishio, Y., Inoguchi, T., Shiba, T. and Xia, P. (1996) Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 45 Suppl 3, S105-108.
10. Zachara, N. E., O'Donnell, N., Cheung, W. D., Mercer, J. J., Marth, J. D. and Hart, G. W. (2004) Dynamic OGlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279, 30133-30142.
11. Jones, S. P., Zachara, N. E., Ngoh, G. A., Hill, B. G., Teshima, Y., Bhatnagar, A., Hart, G. W. and Marban, E. (2008) Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117, 1172-1182.
12. Nigro, J., Osman, N., Dart, A. M. and Little, P. J. (2006) Insulin resistance and atherosclerosis. Endocr. Rev. 27, 242-259.
13. McClain, D. A., Paterson, A. J., Roos, M. D., Wei, X. and Kudlow, J. E. (1992) Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 89, 8150-8154.
14. Nerlich, A. G., Sauer, U., Kolm-Litty, V., Wagner, E., Koch, M. and Schleicher, E. D. (1998) Expression of glutamine: fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47, 170-178.
15. Yki-Jarvinen, H. (1998) Toxicity of hyperglycaemia in type 2 diabetes. Diabetes Metab. Rev. 14 Suppl 1, S45-50.
16. Hirano, K., Derkach, D. N., Hirano, M., Nishimura, J. and Kanaide, H. (2003) Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain. Mol. Cell. Biochem. 248, 105-114.
17. Hirata, K., Kikuchi, A., Sasaki, T., Kuroda, S., Kaibuchi, K., Matsuura, Y., Seki, H., Saida, K. and Takai, Y. (1992) Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem. 267, 8719-8722.
18. Izawa, T., Fukata, Y., Kimura, T., Iwamatsu, A., Dohi, K. and Kaibuchi, K. (2000) Elongation factor-1 alpha is a novel substrate of rho-associated kinase. Biochem. Biophys. Res. Commun. 278, 72-78.
19. Eto, M., Ohmori, T., Suzuki, M., Furuya, K. and Morita, F. (1995) A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem. 118, 1104-1107.
20. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325-1358.
21. Kawamura, H., Yokote, K., Asaumi, S., Kobayashi, K., Fujimoto, M., Maezawa, Y., Saito, Y. and Mori, S. (2004) High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24, 276-281.
22. Kemp, B. K. and Cocks, T. M. (1995) Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Br. J. Pharmacol. 116, 2183-2190.
23. Pang, H., Guo, Z., Su, W., Xie, Z., Eto, M. and Gong, M. C. (2005) RhoA-Rho kinase pathway mediates thrombinand U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 289, C352-60.
24. Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. (1997) Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49, 157-230.
25. 2+ and contraction in vascular smooth muscle. Eur. J. Pharmacol. 223, 157-162.
26. Morishige, K., Shimokawa, H., Eto, Y., Kandabashi, T., Miyata, K., Matsumoto, Y., Hoshijima, M., Kaibuchi, K. and Takeshita, A. (2001) Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler. Thromb. Vasc. Biol. 21, 548-554.
27. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. and Narumiya, S. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-94.
28. Barman, S. A., Zhu, S. and White, R. E. (2009) RhoA/Rhokinase signaling: a therapeutic target in pulmonary hypertension. Vasc. Health Risk Manag. 5, 663-671.
29. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A. and Kaibuchi, K. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
30. Jeon, S. B., Kim, G., Kim, J. I., Seok, Y. M., Kim, S. H., Suk, K., Shin, H. M., Lee, Y. H. and Kim, I. K. (2007) Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit. Clin. Exp. Pharmacol. Physiol. 34, 1116-1120.
31. Gross, B. J., Kraybill, B. C. and Walker, S. (2005) Discovery of O-GlcNAc transferase inhibitors. J. Am. Chem. Soc. 127, 14588-4589.